Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
To study the treatment efficacy of zanzalintinib monotherapy in patients with advanced and/or metastatic bone sarcomas.
Bone Sarcomas
Estimated
~$10 – $6,250
M.D. Anderson Cancer CenterNCT07193550
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about t…
Bone SarcomasFinancial Toxicity
Estimated
~$10 – $750
M.D. Anderson Cancer CenterNCT07215611